SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venmax Drugs and Pharmaceuticals informs about disclosure

05 May 2025 Evaluate
Pursuant to SEBI Circular dated August 10, 2021, with regard to fund raising by issuance of debt securities by large entities, Venmax Drugs and Pharmaceuticals has informed that the Company does not fulfil the criteria specified in the above-mentioned SEBI Circular and hence as on 31st March 2025 the company does not fall in the category of ‘Large Corporate’.

The above information is a part of company’s filings submitted to BSE.

Venmax Drugs&Pharma Share Price

26.69 0.45 (1.71%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×